497 related articles for article (PubMed ID: 20411217)
1. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy.
Febrer A; Rodriguez N; Alias L; Tizzano E
J Rehabil Med; 2010 Mar; 42(3):228-31. PubMed ID: 20411217
[TBL] [Abstract][Full Text] [Related]
2. Spinal muscular atrophy: survival pattern and functional status.
Chung BH; Wong VC; Ip P
Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
[TBL] [Abstract][Full Text] [Related]
3. Leg muscle function and fatigue during walking in spinal muscular atrophy type 3.
Montes J; Dunaway S; Garber CE; Chiriboga CA; De Vivo DC; Rao AK
Muscle Nerve; 2014 Jul; 50(1):34-9. PubMed ID: 24122959
[TBL] [Abstract][Full Text] [Related]
4. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869
[TBL] [Abstract][Full Text] [Related]
5. Muscle strength and motor function in children and adolescents with spinal muscular atrophy II and III.
Kroksmark AK; Beckung E; Tulinius M
Eur J Paediatr Neurol; 2001; 5(5):191-8. PubMed ID: 11585107
[TBL] [Abstract][Full Text] [Related]
6. Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study.
Werlauff U; Vissing J; Steffensen BF
Neuromuscul Disord; 2012 Dec; 22(12):1069-74. PubMed ID: 23127961
[TBL] [Abstract][Full Text] [Related]
7. The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy.
Nelson L; Owens H; Hynan LS; Iannaccone ST;
Neuromuscul Disord; 2006 Jun; 16(6):374-80. PubMed ID: 16632361
[TBL] [Abstract][Full Text] [Related]
8. Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study.
Kirschner J; Schorling D; Hauschke D; Rensing-Zimmermann C; Wein U; Grieben U; Schottmann G; Schara U; Konrad K; Müller-Felber W; Thiele S; Wilichowski E; Hobbiebrunken E; Stettner GM; Korinthenberg R
Neuromuscul Disord; 2014 Feb; 24(2):134-42. PubMed ID: 24300782
[TBL] [Abstract][Full Text] [Related]
9. Reliability of 4 outcome measures in pediatric spinal muscular atrophy.
Iannaccone ST; Hynan LS;
Arch Neurol; 2003 Aug; 60(8):1130-6. PubMed ID: 12925371
[TBL] [Abstract][Full Text] [Related]
10. Muscle fatigue in spinal muscular atrophy.
Iannaccone ST; White M; Browne R; Russman B; Buncher R; Samaha FJ
J Child Neurol; 1997 Aug; 12(5):321-6. PubMed ID: 9378900
[TBL] [Abstract][Full Text] [Related]
11. Spinal muscular atrophy type III: trying to understand subtle functional change over time--a case report.
Dunaway S; Montes J; Ryan PA; Montgomery M; Sproule DM; De Vivo DC
J Child Neurol; 2012 Jun; 27(6):779-85. PubMed ID: 22156787
[TBL] [Abstract][Full Text] [Related]
12. Therapeutics development for spinal muscular atrophy.
Sumner CJ
NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261
[TBL] [Abstract][Full Text] [Related]
13. Physical characteristics and applicability of standard assessment methods in a total population of spinal muscular atrophy type II patients.
Werlauff U; Steffensen BF; Bertelsen S; Fløytrup I; Kristensen B; Werge B
Neuromuscul Disord; 2010 Jan; 20(1):34-43. PubMed ID: 19969460
[TBL] [Abstract][Full Text] [Related]
14. Spinal muscular atrophy diagnostics.
Prior TW
J Child Neurol; 2007 Aug; 22(8):952-6. PubMed ID: 17761649
[TBL] [Abstract][Full Text] [Related]
15. Differences in isometric neck muscle strength between healthy controls and women with chronic neck pain: the use of a reliable measurement.
Cagnie B; Cools A; De Loose V; Cambier D; Danneels L
Arch Phys Med Rehabil; 2007 Nov; 88(11):1441-5. PubMed ID: 17964885
[TBL] [Abstract][Full Text] [Related]
16. Training improves oxidative capacity, but not function, in spinal muscular atrophy type III.
Madsen KL; Hansen RS; Preisler N; Thøgersen F; Berthelsen MP; Vissing J
Muscle Nerve; 2015 Aug; 52(2):240-4. PubMed ID: 25418505
[TBL] [Abstract][Full Text] [Related]
17. Features of motor control in patients with proximal childhood spinal muscle atrophy (pilot study).
Bojakowski J; Dimitrijevic MR; Hausmanowa-Petrusewicz I; Sherwood AM; Wawro AW; Zalewska E
Electromyogr Clin Neurophysiol; 1993 Sep; 33(6):375-83. PubMed ID: 8223338
[TBL] [Abstract][Full Text] [Related]
18. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
[TBL] [Abstract][Full Text] [Related]
19. The effect of hydroxyurea in spinal muscular atrophy cells and patients.
Liang WC; Yuo CY; Chang JG; Chen YC; Chang YF; Wang HY; Ju YH; Chiou SS; Jong YJ
J Neurol Sci; 2008 May; 268(1-2):87-94. PubMed ID: 18166199
[TBL] [Abstract][Full Text] [Related]
20. Natural history of SMA IIIb: muscle strength decreases in a predictable sequence and magnitude.
Deymeer F; Serdaroglu P; Parman Y; Poda M
Neurology; 2008 Aug; 71(9):644-9. PubMed ID: 18725590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
